- Home
- ITRG vs ETON Comparison
ITRG vs ETON Comparison
Compare ITRG & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- ETON
- Stock Information
- Founded
- ITRG 1997
- ETON 2017
- Country
- ITRG Canada
- ETON United States
- Employees
- ITRG N/A
- ETON N/A
- Industry
- ITRG Precious Metals
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- ETON Health Care
- Exchange
- ITRG Nasdaq
- ETON Nasdaq
- Market Cap
- ITRG 277.2M
- ETON 388.3M
- IPO Year
- ITRG N/A
- ETON 2018
- Fundamental
- Price
- ITRG $1.48
- ETON $14.85
- Analyst Decision
- ITRG Strong Buy
- ETON Strong Buy
- Analyst Count
- ITRG 1
- ETON 3
- Target Price
- ITRG $2.75
- ETON $29.67
- AVG Volume (30 Days)
- ITRG 1.1M
- ETON 621.3K
- Earning Date
- ITRG 08-13-2025
- ETON 08-07-2025
- Dividend Yield
- ITRG N/A
- ETON N/A
- EPS Growth
- ITRG N/A
- ETON N/A
- EPS
- ITRG N/A
- ETON N/A
- Revenue
- ITRG $87,375,000.00
- ETON $48,327,000.00
- Revenue This Year
- ITRG $746.16
- ETON $103.21
- Revenue Next Year
- ITRG N/A
- ETON $51.34
- P/E Ratio
- ITRG N/A
- ETON N/A
- Revenue Growth
- ITRG N/A
- ETON 40.88
- 52 Week Low
- ITRG $0.79
- ETON $3.25
- 52 Week High
- ITRG $1.95
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- ITRG 43.07
- ETON 54.31
- Support Level
- ITRG $1.44
- ETON $13.78
- Resistance Level
- ITRG $1.55
- ETON $16.27
- Average True Range (ATR)
- ITRG 0.08
- ETON 0.83
- MACD
- ITRG -0.01
- ETON 0.32
- Stochastic Oscillator
- ITRG 19.70
- ETON 77.67
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.